Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 22-2480896 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To support the development of new drugs to treat Charcot-Marie-Tooth disease (cmt), to improve the quality of life for people with cmt and untimately, to fund a cure.
Total Revenue
$5.8M
FY2024
Total Expenses
$5.8M
FY2024
Net Assets
$9.5M
Program Ratio
88.8%
expenses on programs
Employees
13
Volunteers
125
Board Members
17
Voting
17
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.